Implantable Devices and Magnetic Resonance Imaging

Heart Lung and Circulation

Volumn 21, Issue 6-7, 2012, Pages 358-363

  Hsu, Chijen ^a   Parker, Geoffrey ^a   Puranik, Rajesh ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Implantable cardioverter defibrillator; Magnetic resonance imaging; Pacemaker

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL STUDY; CORONARY STENT; DEFIBRILLATOR; ENDOCARDIAL LEAD; EPICARDIAL PACING WIRE; EQUIPMENT DESIGN; HEART PACING; HEART VALVE PROSTHESIS; HUMAN; MAGNETIC FIELD; MECHANICS; NUCLEAR MAGNETIC RESONANCE SCANNER; PACEMAKER; PATIENT SAFETY; PRIORITY JOURNAL; RADIATION PHYSICS; RISK ASSESSMENT;

DEFIBRILLATORS, IMPLANTABLE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84862219039     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.04.004     Document Type: Article

References (37)

1. Gotte M.J., Russel I.K., Roest G.J., Germans T., Veldkamp R.F., Knaapen P., et al. Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective. Neth Heart J 2010, 18:31-37.
2. Kalin R., Stanton M.S. Current clinical issues for MRI scanning of pacemaker and defibrillator patients. Pacing Clin Electrophysiol 2005, 28:326-328.
3. Faris O.P., Shein M. Food and Drug Administration perspective: magnetic resonance imaging of pacemaker and implantable cardioverter-defibrillator patients. Circulation 2006, 114:1232-1233.
4. Sorrentino R.A. A novel MRI-safe dual-chamber pacemaker system: its time has come. Heart Rhythm 2011, 8:74-75.
5. Kramer C.M., Budoff M.J., Fayad Z.A., Ferrari V.A., Goldman C., Lesser J.R., et al. ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology. Circulation 2007, 116:1318-1335.
6. Roguin A., Zviman M.M., Meininger G.R., Rodrigues E.R., Dickfeld T.M., Bluemke D.A., et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5T. Circulation 2004, 110:475-482.
7. Achenbach S., Moshage W., Diem B., Bieberle T., Schibgilla V., Bachmann K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997, 134:467-473.
8. Baikoussis N.G., Apostolakis E., Papakonstantinou N.A., Sarantitis I., Dougenis D. Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Ann Thorac Surg 2011, 91:2006-2011.
9. Martin E.T., Coman J.A., Shellock F.G., Pulling C.C., Fair R., Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004, 43:1315-1324.
10. Sommer T., Naehle C.P., Yang A., Zeijlemaker V., Hackenbroch M., Schmiedel A., et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006, 114:1285-1292.
11. Shinbane J.S., Colletti P.M., Shellock F.G. Magnetic resonance imaging in patients with cardiac pacemakers: era of " MR Conditional" designs. J Cardiovasc Magn Reson 2011, 13:63.
12. Roguin A., Schwitter J., Vahlhaus C., Lombardi M., Brugada J., Vardas P., et al. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008, 10:336-346.
13. Levine G.N., Gomes A.S., Arai A.E., Bluemke D.A., Flamm S.D., Kanal E., et al. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation 2007, 116:2878-2891.
14. Luechinger R., Duru F., Scheidegger M.B., Boesiger P., Candinas R. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001, 24:199-205.
15. Reynolds M.R., Zimetbaum P. Magnetic resonance imaging and cardiac devices: how safe is safe enough?. Ann Intern Med 2011, 155:470-472.
16. Fontaine J.M., Mohamed F.B., Gottlieb C., Callans D.J., Marchlinski F.E. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998, 21:1336-1339.
17. Hayes D.L., Holmes D.R., Gray J.E. Effect of 1.5tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol 1987, 10:782-786.
18. Walton C., Gergely S., Economides A.P. Platinum pacemaker electrodes: origins and effects of the electrode-tissue interface impedance. Pacing Clin Electrophysiol 1987, 10:87-99.
19. Erlebacher J.A., Cahill P.T., Pannizzo F., Knowles R.J. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol 1986, 57:437-440.
20. Gimbel J.R., Johnson D., Levine P.A., Wilkoff B.L. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996, 19:913-919.
21. Sommer T., Vahlhaus C., Lauck G., von Smekal A., Reinke M., Hofer U., et al. MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 0.5T. Radiology 2000, 215:869-879.
22. Buendia F., Sanchez-Gomez J.M., Sancho-Tello M.J., Olague J., Osca J., Cano O., et al. Nuclear magnetic resonance imaging in patients with cardiac pacing devices. Rev Esp Cardiol 2010, 63:735-739.
23. Naehle C.P., Strach K., Thomas D., Meyer C., Linhart M., Bitaraf S., et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009, 54:549-555.
24. Nazarian S., Hansford R., Roguin A., Goldsher D., Zviman M.M., Lardo A.C., et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011, 155:415-424.
25. Luechinger R., Zeijlemaker V.A., Pedersen E.M., Mortensen P., Falk E., Duru F., et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005, 26:376-383.
26. Nazarian S., Roguin A., Zviman M.M., Lardo A.C., Dickfeld T.L., Calkins H., et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5tesla. Circulation 2006, 114:1277-1284.
27. Gimbel J.R., Kanal E., Schwartz K.M., Wilkoff B.L. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005, 28:270-273.
28. Roguin A., Goldsher D. Magnetic resonance imaging and implantable cardiac electronic devices: it's not what we can do, it's what we should do. Isr Med Assoc J 2010, 12:436-438.
29. Mollerus M., Albin G., Lipinski M., Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2008, 31:1241-1245.
30. Burke P.T., Ghanbari H., Alexander P.B., Shaw M.K., Daccarett M., Machado C. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010, 28:59-66.
31. Porto I., Selvanayagam J., Ashar V., Neubauer S., Banning A.P. Safety of magnetic resonance imaging one to three days after bare metal and drug-eluting stent implantation. Am J Cardiol 2005, 96:366-368.
32. Gerber T.C., Fasseas P., Lennon R.J., Valeti V.U., Wood C.P., Breen J.F., et al. Clinical safety of magnetic resonance imaging early after coronary artery stent placement. J Am Coll Cardiol 2003, 42:1295-1298.
33. Condon B., Hadley D.M. Potential MR hazard to patients with metallic heart valves: the Lenz effect. J Magn Reson Imaging 2000, 12:171-176.
34. Giroletti E., Corbucci G. Cardiac magnetic resonance imaging: patient safety considerations. Phys Med 2005, 21:5-13.
35. Junttila M.J., Fishman J.E., Lopera G.A., Pattany P.M., Velazquez D.L., Williams A.R., et al. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011, 97:1852-1856.
36. Neuzil P., Taborsky M., Rezek Z., Vopalka R., Sediva L., Niederle P., et al. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. Europace 2007, 9:98-104.
37. Wilkoff B.L., Bello D., Taborsky M., Vymazal J., Kanal E., Heuer H., et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011, 8:65-73.